0

Correlation Analysis of Urine Metabolites and Clinical Staging in Patients With Ovarian Cancer

Ting Jiang, Yunliang Lin, Haiqin Yin, Shanshan Wang, Qinglei Sun, Peihai Zhang, Wenxiang Bi

Int J Clin Exp Med. 2015 Oct 15;8(10):18165-71.

PMID: 26770415

Abstract:

This study is to investigate the correlation between urine metabolites and clinical staging in patients with ovarian cancer. The urina sanguinis from 56 cases of primary epithelial ovarian cancer patients and 15 healthy volunteers was collected and the urine metabolites were extracted. Ultra high performance liquid chromatography/time-of-flight mass spectrometry (UPLC-Q-TOF-MS) analysis was performed. Principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA) were used to analyze the mass spectrometry data. Database retrieval and comparison of the screened metabolites were performed and one-way ANOVA and least significant difference (LSD) t test were carried out. PCA analysis of UPLC-Q-TOF-MS results showed that the score plots of samples from healthy people and patients with ovarian cancer at different clinical stages were separated. Further PLS-DA analysis significantly improved the classification results. The R(2)X was 0.757, the R(2)Y was 0.977 and the Q(2)Y was 0.87, indicating that the model stability and predictability were good. Eight metabolites, including N-acetylneuraminic acid-9-phosphate, 5'-methioadenosine, uric acid-3-nucleoside, pseudouridine, L-valine, succinic acid, L-proline and β-nicotinamide mononucleotide were identified. The contents of these metabolites increased with the development of the disease. There was correlation between urine metabolites and clinical staging in patients with ovarian cancer.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP1094617 β-Nicotinamide mononucleotide β-Nicotinamide mononucleotide 1094-61-7 Price
qrcode